Sinopol® prescribing information, February 2019.
Bellver J, Rodriguez-Tabernero L, Robles A, Munoz E, Martinez F, Landeras J. et al. Polycystic ovary syndrome throughout a woman's life. J Assist Reprod Genet 2018;35:25–39. Doi: 10.1007/s10815-017-1047-7.
Cappelli V, Musacchio MC, Bulfoni A, Morgante G, De Leo V. Natural molecules for the therapy of hyperandrogenism and metabolic disorders in PCOS. Eur Rev Med Pharmacol Sci 2017; 21(2 Suppl):15-29.
Mohamaddi M. Oxidative Stress and Polycystic Ovary Syndrome: A Brief Review. Int J Prev Med 2019;10:86. Doi: 10.4103/ijpvm.IJPVM_576_17.
Mayo Clinic. Polycystic ovary syndrome (PCOS) [online] [cited December 2022]; Available from: https://www.mayoclinic.org/diseases-conditions/pcos/symptoms-causes/syc-20353439?p=1.
NHS. Polycystic ovary syndrome. Treatment [online] [cited December 2022]; Available from: https://www.nhs.uk/conditions/polycystic-ovary-syndrome-pcos/treatment/#:~:text=Polycystic%20ovary%20syndrome%20(PCOS)%20cannot,discussed%20in%20more%20detail%20below.
Rago R, Marcucci I, Leto G, Caponecchia L, Salacone P, Bonanni P, et al. Effect of myo-inositol and alpha-lipoic acid on oocyte quality in polycystic ovary syndrome non-obese women undergoing in vitro fertilization: a pilot study. J Biol Regulators Homeostatic Agents 2015;29(4):1-1
Teede HJ, Misso ML, Deeks AA, et al. Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline. Med J Aust. 2011 Sep 19;195(6):S65-112
Deswal R, Narwal V, Dang A, Pundir CS. The Prevalence of Polycystic Ovary Syndrome: A Brief Systematic Review. J Hum Reprod Sci. 2020;13(4):261-271.
NHS. Polycystic ovary syndrome. Causes [online] October 2022 [cited December 2022]; Available from: https://www.nhs.uk/conditions/polycystic-ovary-syndrome-pcos/causes/.
Rojas J, Chávez M, Olivar L, et al. Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth. Int J Reprod Med. 2014;2014:719050.
Everything You Should Know About Oxidative Stress [online] 2018 [cited December 2022]; Available from: https://www.healthline.com/health/oxidative-stress
Ndefo UA, Eaton A, Green MR. Polycystic ovary syndrome: a review of treatment options with a focus on pharmacological approaches. P T. 2013;38(6):336-55.
Polycystic Ovary Syndrome (PCOS) [online] [cited December 2022]; Available from: https://www.hopkinsmedicine.org/health/conditions-and-diseases/polycystic-ovary-syndrome-pcos
Centers for Disease Control and Prevention. PCOS (Polycystic Ovary Syndrome) and Diabetes [online] March 2020 [cited December 2022]; Available from: https://www.cdc.gov/diabetes/basics/pcos.html.
NHS. Polycystic ovary syndrome. Overview [online] October 2022 [cited December 2022]; Available from: https://www.nhs.uk/conditions/polycystic-ovary-syndrome-pcos/
Emotional Well-being and PCOS [online] [cited December 2022]; Available from URL: https://www.monash.edu/__data/assets/pdf_file/0004/1410853/PCOS-and-Emotional-Well-being.pdf
Williams S, Sheffield D, Knibb RC. The Polycystic Ovary Syndrome Quality of Life scale (PCOSQOL): Development and preliminary validation. Health Psychology Open 2018:1-8. DOI: 10.1177/2055102918788195.
Pizzino G, Irrera N, Cucinotta M, et al. Oxidative Stress: Harms and Benefits for Human Health. Oxid Med Cell Longev. 2017;2017:8416763.
Villines Z. How do free radicals affect the body? [online] 2017 [cited December 2022]; Available from: https://www.medicalnewstoday.com/articles/318652
Kumar K. What Does Oxidative Stress Mean? Free Radical Damage [online] 2021 [cited December 2022]; Available from: https://www.medicinenet.com/what_does_oxidative_stress_mean/article.htm
MedicineNet. Sugar Detox: Hype or Hope? [online] [cited December 2022]; Available from: https://www.medicinenet.com/sugar_addiction_pictures_slideshow/article.htm
Agarwal A, Aponte-Mellado A, Premkumar BJ, et al. The effects of oxidative stress on female reproduction: a review. Reprod Biol Endocrinol 2012;10:49. http://www.rbej.com/content/10/1/49.
Daiber A, Kröller-Schön S, Oelze M, et al. Oxidative stress and inflammation contribute to traffic noise-induced vascular and cerebral dysfunction via uncoupling of nitic oxide synthases. Redox Biology 2020;34:101506. https://doi.org/10.1016/j.redox.2020.101506
Barber TM, Hanson P, Weickert MO, et al. Obesity and Polycystic Ovary Syndrome: Implications for Pathogenesis and Novel Management Strategies. Clin Med Insights Reprod Health. 2019;13:1179558119874042
Monash University. Lifestyle and PCOS [online] [cited December 2022]; Available from: https://www.monash.edu/__data/assets/pdf_file/0006/1410855/PCOS-and-Lifestyle-Management.pdf
Kanbour SA, Dobs AS. Hyperandrogenism in Women with Polycystic Ovarian Syndrome: Pathophysiology and Controversies.Androgens: Clinical Research and Therapeutics. 2022:22-30.
Victoria State Government. Department of Health. Better Health Channel. Androgen deficiency in women [online] 2022 [cited December 2022]; Available from: https://www.betterhealth.vic.gov.au/health/conditionsandtreatments/androgen-deficiency-in-women
Mayo Clinic. Hirsutism [online] cited December 2022]; Available from: https://www.mayoclinic.org/diseases-conditions/hirsutism/symptoms-causes/syc-20354935
National Library of Medicine. Medline Plus. Ovarian overproduction of androgens [online] [cited December 2022]; Available from: https://medlineplus.gov/ency/article/001165.htm
Mayo Clinic. Polycystic ovary syndrome (PCOS) [online] [cited December 2022]; Available from: https://www.mayoclinic.org/diseases-conditions/pcos/diagnosis-treatment/
Genazzani AD, Despini G, Santagni S, et al. Effects of a Combination of Alpha Lipoic Acid and Myo-Inositol on Insulin Dynamics in Overweight/Obese Patients with PCOS. Endocrinol Metab Synd 2014,3(3). DOI: 10.4172/2161-1017.1000140.
Gambera, Visenzi, Fratus, et al. Alternative insulin-sensitizers (Lipoic acid and Inositol) in polycystic ovary syndrome (PCOS). Giorn It Ost Gin (Giornale Italiano di Ostetriciae Ginecologia) 2012; XXXIV(1):182-183.
Carbonelli MG, Di Renzo L, Bigioni M, et al. α-Lipoic Acid Supplementation: A Tool for Obesity Therapy? Curr Pharmaceut Design 2010;16:840-846
Proprietary name (and dosage form): SINOPOL® granules. Composition: Each sachet contains: Myo-inositol 1 000 mg, Alpha Lipoic Acid 400 mg and Folic Acid 200 μg. Complementary Medicine: Health Supplement. D34.12 Multiple Substance formulation. This unregistered medicine has not been evaluated by SAHPRA for its quality, safety or intended use. For full prescribing information, refer to the professional information available at www.inovapharma.co.za. Further information is available on request from iNova Pharmaceuticals. Name and business address of applicant: iNova Pharmaceuticals (Pty) Limited. Co. Reg. No. 1952/001640/07, 15e Riley Road, Bedfordview. Tel. No. 011 087 0000. www.inovapharma.co.za.